Roberts M Scot (CIK 1705905) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-03). Recent activity: Buy ALT (875 shares), Buy ALT (9,275 shares), Sell ALT (2,859 shares), Buy ALT (5,567 shares), Buy ALT (7,775 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-03 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Buy | 875 | $2,112 |
| 2026-02-03 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Buy | 9,275 | $0 |
| 2026-02-03 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Sell | 2,859 | $16,010 |
| 2026-02-03 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Buy | 5,567 | $17,091 |
| 2026-02-03 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Buy | 7,775 | $0 |
| 2026-02-03 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Sell | 2,329 | $12,926 |
| 2026-01-29 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Buy | 15,850 | $0 |
| 2026-01-29 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Sell | 4,748 | $29,343 |
| 2026-01-27 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Buy | 14,600 | $0 |
| 2026-01-27 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Sell | 4,373 | $24,052 |
| 2025-08-04 | Altimmune, Inc. (ALT) | Chief Scientific Officer | Buy | 846 | $2,656 |
Source: SEC Form 4 filings · as of 2026-08-03